Utilizing indication and weight-based dosing helps proactively and prospectively prevent inappropriate dose escalation and ultimately avoid wasteful spend More
A range of new treatment options for AD are expected to come to market in the next couple years. Effective management strategies can help payors manage cost. More
Our proven strategies including step therapy, Specialty Guideline Management, and cross-benefit management can help clients better manage costs for the growing number of IBD... More
If ERISA pre-emption is not upheld for self-funded ERISA plans using PBMs to administer prescription drug benefits, we believe the implications may create unsustainable complexity... More
Over the past dozen years, several new treatments have come to market with the first oral preventive expected to be approved in December. Targeted management to help balance... More
Biosimilars are a critical tool PBMs can use to help increase market competition and lower costs – we made changes to our template formularies for categories that now have... More
CVS Kidney Care launched the first phase of its chronic kidney disease management services to help improve quality of life and outcomes for an under-served patient population More